Log in to save to my catalogue

Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy i...

Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1653119928

Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation

About this item

Full title

Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation

Publisher

United States: Public Library of Science

Journal title

PloS one, 2015-02, Vol.10 (2), p.e0115543-e0115543

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

To investigate a multimodal, multiparametric perfusion MRI / 18F-fluoro-deoxyglucose-(18F-FDG)-PET imaging protocol for monitoring regorafenib therapy effects on experimental colorectal adenocarcinomas in rats with immunohistochemical validation.
Human colorectal adenocarcinoma xenografts (HT-29) were implanted subcutaneously in n = 17 (n = 10 t...

Alternative Titles

Full title

Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1653119928

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1653119928

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0115543

How to access this item